Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022

被引:4
作者
Song, Wenpeng [1 ]
Wang, Hao [1 ]
Wang, Xiaoyan [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Stomatol, Beijing, Peoples R China
[2] Capital Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Beijing, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Sjogren 's syndrome; Sicca syndrome; Treatment; Therapy; Disease management; Bibliometric analysis; OPEN-LABEL; CLASSIFICATION CRITERIA; REGENERATIVE MEDICINE; RITUXIMAB TREATMENT; ABATACEPT TREATMENT; AMERICAN-COLLEGE; GENE-THERAPY; DOUBLE-BLIND; DATA-DRIVEN; STEM-CELLS;
D O I
10.1016/j.heliyon.2023.e23216
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Sjogren's syndrome (SS) is an autoimmune disease that mainly affects the salivary and lacrimal glands and further leads to dry mouth and eyes. In recent years, knowledge about the treatment of SS is developing rapidly. This study aims to assess research progress on SS treatment using a bibliometric approach and to identify research hotspots and emerging trends in this area. Methods: The publications related to the treatment of SS were retrieved from the Science Citation Index Expanded (SCI-E) database. The following search terms were used to extract document data: TS=(Sjogren* OR Sicca*) AND TS= (Treat* OR Therap* OR Disease Management). Articles and review articles published in English from 1900 to 2022 were selected. After the manual screening, the publication data were exported to a plain text file and applied for cooperative network analysis, keyword analysis, and reference co-citation analysis by using CiteSpace. Results: A total of 2038 publications were included in the analysis from 571 journals by 9063 authors. The annual number of published studies and times cited showed an overall upward trend since 1992. There was a degree of national/regional collaboration in this area, but direct collaboration between institutions and authors was still lacking. The country with the highest number of publications was in the United States, followed by China and Japan. Five SS-related treatments as the research hotspots were summarized by analyzing keywords and references, including immunosuppressive and anti-inflammatory therapy, regenerative therapy, gene therapy, surgical treatment, and symptomatic treatment. Among them, B cells, T cells, mucosalassociated invariant T (MAIT) cells, mesenchymal stem cells (MSCs), rituximab, belimumab, cell-target therapy, and immunosuppressive and anti-inflammatory therapy were emerging trends in this field. Conclusions: This study conducted a data-based and objective introduction to the treatment of SS from a fresh perspective. An analysis of the intellectual bases, research hotspots, and emerging trends in the field will contribute to future research and treatment decisions, which will ultimately benefit SS patients.
引用
收藏
页数:15
相关论文
共 112 条
[1]   Evaluation of Histologic, Serologic, and Clinical Changes in Response to Abatacept Treatment of Primary Sjogren's Syndrome: A Pilot Study [J].
Adler, Sabine ;
Koerner, Meike ;
Foerger, Frauke ;
Huscher, Doerte ;
Caversaccio, Marco-Domenico ;
Villiger, Peter M. .
ARTHRITIS CARE & RESEARCH, 2013, 65 (11) :1862-1868
[2]   Publication activity in the field of Sjogren's syndrome: a ten-year web of science based analysis [J].
Akyol, Ahmet ;
Kocyigit, Burhan Fatih .
RHEUMATOLOGY INTERNATIONAL, 2021, 41 (04) :763-769
[3]   In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjogren's syndrome [J].
Alunno, Alessia ;
Montanucci, Pia ;
Bistoni, Onelia ;
Basta, Giuseppe ;
Caterbi, Sara ;
Pescara, Teresa ;
Pennoni, Ilaria ;
Bini, Vittorio ;
Bartoloni, Elena ;
Gerli, Roberto ;
Calafiore, Riccardo .
RHEUMATOLOGY, 2015, 54 (01) :163-168
[4]  
ARRIAGA MA, 1990, LARYNGOSCOPE, V100, P1270
[5]   A Scientometric Review of Rasch Measurement: The Rise and Progress of a Specialty [J].
Aryadoust, Vahid ;
Tan, Hannah Ann Hui ;
Ng, Li Ying .
FRONTIERS IN PSYCHOLOGY, 2019, 10
[6]   Efficacy and safety of abatacept in active primary Sjogren's syndrome: results of a phase III, randomised, placebo-controlled trial [J].
Baer, Alan N. ;
Gottenberg, Jacques-Eric ;
St Clair, E. William ;
Sumida, Takayuki ;
Takeuchi, Tsutomu ;
Seror, Raphaele ;
Foulks, Gary ;
Nys, Marleen ;
Mukherjee, Sumanta ;
Wong, Robert ;
Ray, Neelanjana ;
Bootsma, Hendrika .
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) :339-348
[7]   Sjogren Syndrome and Other Causes of Sicca in Older Adults [J].
Baer, Alan N. ;
Walitt, Brian .
CLINICS IN GERIATRIC MEDICINE, 2017, 33 (01) :87-+
[8]   Advances in salivary gland gene therapy - oral and systemic implications [J].
Baum, Bruce J. ;
Alevizos, Ilias ;
Chiorini, John A. ;
Cotrim, Ana P. ;
Zheng, Changyu .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (10) :1443-1454
[9]   TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis [J].
Bodewes, Iris L. A. ;
Huijser, Erika ;
van Helden-Meeuwsen, Cornelia G. ;
Tas, Liselotte ;
Huizinga, Ruth ;
Dalm, Virgil A. S. H. ;
van Hagen, P. Martin ;
Groot, Noortje ;
Kamphuis, Sylvia ;
van Daele, Paul L. A. ;
Versnel, Marjan A. .
JOURNAL OF AUTOIMMUNITY, 2018, 91 :97-102
[10]  
BONE RC, 1985, LARYNGOSCOPE, V95, P295